LONDON, Jan. 17, 2011 /PRNewswire/ — Chiltern International
Limited (Chiltern), a global contract research organization (CRO),
announced that Chiltern has won multiple awards at the PharmaTimes
Annual Awards 2010 ceremony held at the Park Plaza Riverbank Hotel
in London. The competition, established in 1999, celebrates the
competence and ability of top clinical research professionals.
Glenn Kerkhof, Chiltern CEO, congratulates all of
Chiltern’s Award Winners and Finalists. “I am very proud of every
Chiltern colleague nominated for an award. They put their best
forward each and every day for our clients and their dedication to
being the best is evident in all they do. These achievements of the
award winners reflect Chiltern’s commitment to deliver expert, high
quality services around the world and I couldn’t be happier that
they have received the recognition that is so well-deserved.”
Chiltern Award WinnersClinical Research Associate of the Year
Gold Award: Helen Chester, Chiltern Resourcing Solutions CRA
outsourced to Roche
Clinical Research Associate of the Year Silver Award: Dawn
Skingle, Sr. Clinical Research Associate
Clinical Research Team of the Year Bronze Award: Daniel
Lowman, Sr. Clinical Research Associate, Kate Backhouse,
Clinical Research Associate 2, Jonathan Kinnell, Sr.
Manager, Clinical Monitoring, Mark Williams, Clinical
Trainer, Europe
Company profileAbout Chiltern:Established in 1982, Chiltern
is a leading global Contract Research Organization with extensive
experience conducting and staffing international Phase I to Phase
IV clinical trials across a broad range of therapeutic areas for a
wide variety of clients. Chiltern has conducted trials in more than
40 countries, has 24 offices and legal entities within 20
countries, resources in 37 countries and employs nearly 1,400
people globally. Chiltern provides Early Phase, Global Clinical
Development, Late
‘/>”/>